Naveris, Inc., a leader in molecular diagnostics for viral cancers, announced the launch of the DART 2.0 prospective clinical trial (NCT05541016) by Mayo Clinic.
The...
Alpenglow Biosciences announced a collaboration with Mayo Clinic to integrate Alpenglow's 3D spatial biology platform to accelerate drug development and advance clinical diagnostics. Alpenglow has...
nference, the AI-driven health technology company, announced publication of a peer-reviewed study in Med that analyzed Mayo Clinic based data with nference artificial intelligence...
Royal Philips, a global leader in health technology, unveiled its vision for interventional medicine by bringing its breakthrough spectral CT imaging technology into a...
